Cardlytics, Inc. Reports Q2 2026 Financial Results

What Happened Cardlytics, Inc. (CDLX) filed a Current Report on Form 8‑K on August 5, 2026 (Item 2.02) announcing its financial results for the three and six months ended June 30, 2026. The company issued a press release with those results and information about a conference call to discuss the quarterly results and recent corporate highlights; the press release is furnished as Exhibit 99.1 to the Form 8‑K. The filing contains no additional financial figures in-line—investors should review Exhibit 99.1 for the detailed earnings, revenue and other metrics.

Key Details

• Filing date: August 5, 2026 (Form 8‑K, Item 2.02 and Item 9.01).
• Reporting periods: three and six months ended June 30, 2026.
• Press release announcing results and a related conference call is furnished as Exhibit 99.1.
• Form 8‑K signed by David Evans, Chief Financial Officer, on August 5, 2026.

Why It Matters This 8‑K signals that Cardlytics has released its quarterly earnings and will discuss them on a conference call—material events that can affect the stock price and investor decisions. Because the 8‑K references a furnished press release for the actual numbers, retail investors should read Exhibit 99.1 (the press release) and consider the conference call transcript or replay to understand revenue, earnings, guidance changes, or key operating updates.